Rome-based Angelini Pharma has inked a multi-year deal with Massachusetts biotech Quiver Bioscience that is designed to advance novel therapies for genetic epilepsies and could garner up to $120 ...
Feb 2026Angelini Pharma secures exclusive global license rights to future identified drug targetsQuiver receives undisclosed advance payment and is eligible for future milestone-dependent payments and ...
Bow quivers don’t get a lot of love, but they should. Many archers will drop over a grand on a new flagship bow and outfit it with a fancy sight, drop-away rest, and even add a pricy front- and ...
The arrow quiver is one of those pieces of gear that bowhunters generally don’t think about too much. Until it’s a problem. The job of the quiver is pretty simple: carry arrows. That’s it. That’s all ...
CAMBRIDGE, Mass., July 01, 2025--(BUSINESS WIRE)--Quiver Bioscience ("Quiver"), a discovery technology and therapeutics company advancing programs for treatment of serious central nervous system (CNS) ...
Angelini Pharma and Quiver Bioscience enter research collaboration and licensing pact to discover and advance novel therapeutics for genetic epilepsies: Rome Wednesday, February 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results